Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II
- PMID: 2254023
- PMCID: PMC313762
- DOI: 10.1128/iai.58.12.3959-3965.1990
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II
Abstract
Escherichia coli O157:H7 strains have been implicated as etiologic agents in food-borne outbreaks of hemorrhagic colitis and the hemolytic-uremic syndrome. A prototype E. coli O157:H7 strain, designated 933, produces Shiga-like toxin I (SLT-I) and SLT-II and harbors a 60-MDa plasmid. In a previous study, streptomycin-treated mice were fed 933 together with a derivative cured of the 60-MDa plasmid (designated 933cu). Strain 933cu colonized poorly, but in approximately one-third of the animals, an isolate of 933cu was obtained from the feces that had regained the ability to colonize well. This isolate, designated 933cu-rev, killed all of the animals when fed alone to mice. In this investigation, two types of experiments were done to assess whether SLT-I, SLT-II, or both contributed to the death of mice fed 933cu-rev. (i) Mice were pretreated with monoclonal antibodies to SLT-I, SLT-II, SLT-I and SLT-II, or cholera toxin (as a control) before infection with 933cu-rev. (ii) Mice were fed either an E. coli K-12 strain carrying cloned SLT-I genes or the same K-12 strain carrying cloned SLT-II genes. The results of both types of experiments indicated that the deaths of the orally infected mice were due solely to SLT-II. Extensive histological and selected electron microscopic examinations of various tissues from the infected animals suggested that death was due to acute renal cortical tubular necrosis consistent with toxic renal damage. These data indicate a critical role for SLT-II, but not SLT-I, in renal damage associated with E. coli O157:H7 infection of streptomycin-treated mice.
Similar articles
-
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.Infect Immun. 1990 Aug;58(8):2438-45. doi: 10.1128/iai.58.8.2438-2445.1990. Infect Immun. 1990. PMID: 2196227 Free PMC article.
-
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.Infect Immun. 1994 Feb;62(2):623-31. doi: 10.1128/iai.62.2.623-631.1994. Infect Immun. 1994. PMID: 8300218 Free PMC article.
-
Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.Infect Immun. 1993 Sep;61(9):3832-42. doi: 10.1128/iai.61.9.3832-3842.1993. Infect Immun. 1993. PMID: 8359904 Free PMC article.
-
Escherichia coli cytotoxins and enterotoxins.Can J Microbiol. 1992 Jul;38(7):734-46. doi: 10.1139/m92-120. Can J Microbiol. 1992. PMID: 1393838 Review.
-
[Anti Shiga-like toxin II(SLT-II) humanized monoclonal antibody].Nihon Rinsho. 2002 Mar;60(3):473-9. Nihon Rinsho. 2002. PMID: 11904961 Review. Japanese.
Cited by
-
Shiga toxin subtypes display dramatic differences in potency.Infect Immun. 2011 Mar;79(3):1329-37. doi: 10.1128/IAI.01182-10. Epub 2011 Jan 3. Infect Immun. 2011. PMID: 21199911 Free PMC article.
-
A novel murine infection model for Shiga toxin-producing Escherichia coli.J Clin Invest. 2012 Nov;122(11):4012-24. doi: 10.1172/JCI62746. Epub 2012 Oct 8. J Clin Invest. 2012. PMID: 23041631 Free PMC article.
-
Prophage induction, but not production of phage particles, is required for lethal disease in a microbiome-replete murine model of enterohemorrhagic E. coli infection.PLoS Pathog. 2019 Jan 10;15(1):e1007494. doi: 10.1371/journal.ppat.1007494. eCollection 2019 Jan. PLoS Pathog. 2019. PMID: 30629725 Free PMC article.
-
Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.Infect Immun. 2005 Aug;73(8):4810-7. doi: 10.1128/IAI.73.8.4810-4817.2005. Infect Immun. 2005. PMID: 16040994 Free PMC article.
-
Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.Infect Immun. 1998 Feb;66(2):636-44. doi: 10.1128/IAI.66.2.636-644.1998. Infect Immun. 1998. PMID: 9453620 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources